首页> 外文期刊>Scientific reports. >Development and Characterization of Lecithin-based Self-assembling Mixed Polymeric Micellar (saMPMs) Drug Delivery Systems for Curcumin
【24h】

Development and Characterization of Lecithin-based Self-assembling Mixed Polymeric Micellar (saMPMs) Drug Delivery Systems for Curcumin

机译:姜黄素基于卵磷脂的自组装混合聚合物胶束(saMPMs)药物递送系统的开发和表征

获取原文
           

摘要

Self-assembling mixed polymeric micelles (saMPMs) were developed for overcoming major obstacles of poor bioavailability (BA) associated with curcumin delivery. Lecithin added was functioned to enlarge the hydrophobic core of MPMs providing greater solubilization capacity. Amphiphilic polymers (sodium deoxycholate [NaDOC], TPGS, CREMOPHOR, or a PLURONIC series) were examined for potentially self-assembling to form MPMs (saMPMs) with the addition of lecithin. Particle size, size distribution, encapsulation efficacy (E.E.), and drug loading (D.L.) of the mixed micelles were optimally studied for their influences on the physical stability and release of encapsulated drugs. Overall, curcumin:lecithin:NaDOC and curcumin:lecithin:PLURONIC P123 in ratios of 2:1:5 and 5:2:20, respectively, were optimally obtained with a particle size of?80%, and a D.L. of 10%. The formulated system efficiently stabilized curcumin in phosphate-buffered saline (PBS) at room temperature or 4?°C and in fetal bovine serum or PBS at 37?°C and delayed the in vitro curcumin release. In vivo results further demonstrated that the slow release of curcumin from micelles and prolonged duration increased the curcumin BA followed oral and intravenous administrations in rats. Thus, lecithin-based saMPMs represent an effective curcumin delivery system, and enhancing BA of curcumin can enable its wide applications for treating human disorders.
机译:自组装混合聚合物胶束(saMPMs)的开发是为了克服与姜黄素输送相关的生物利用度差的主要障碍。添加的卵磷脂的功能是扩大MPM的疏水核心,从而提供更大的增溶能力。检查两亲性聚合物(脱氧胆酸钠[NaDOC],TPGS,CREMOPHOR或PLURONIC系列)的潜在自组装能力,并添加卵磷脂以形成MPM(saMPM)。对混合胶束的粒径,尺寸分布,包封功效(E.E.)和载药量(D.L.)进行了优化研究,以研究其对包封药物的物理稳定性和释放的影响。总的来说,最佳获得姜黄素:卵磷脂:NaDOC和姜黄素:卵磷脂:PLURONIC P123的比例分别为2:1:5和5:2:20,粒径为?80%,D.L。 > 10%。配制的系统可在室温或4°C下有效地稳定姜黄素在磷酸盐缓冲液(PBS)中和37°C下在胎牛血清或PBS中的稳定性,并延迟体外姜黄素的释放。体内结果进一步表明,在大鼠口服和静脉内给药后,姜黄素从胶束中的缓慢释放和持续时间的延长增加了姜黄素的BA。因此,基于卵磷脂的saMPM代表了有效的姜黄素递送系统,增强姜黄素的BA可以使其广泛用于治疗人类疾病。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号